Wednesday, April 23, 2025

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Glenmark Pharmaceuticals Recalls 1.5 Million Bottles of Generic ADHD Drug

Glenmark Pharmaceuticals Recalls 1.5 Million Bottles of Generic ADHD Drug

Glenmark Pharmaceuticals, Inc., a subsidiary of Glenmark Pharmaceuticals Ltd. of Mumbai, India, is recalling 1.476 million bottles of a generic Attention Deficit Hyperactivity Disorder (ADHD) medication called atomoxetine from the U.S market, according to the U.S. Food and Drug Administration (FDA).1 Eli Lilly had once marketed the branded version of the drug, Strattera, but stopped […]

COVID Antiviral Paxlovid Provides “No Significant Benefit” to Vaccinated Seniors

COVID Antiviral Paxlovid Provides “No Significant Benefit” to Vaccinated Seniors

Paxlovid, the antiviral drug that became the go-to treatment for SARS-CoV-2 infections during the pandemic, did not reduce hospitalizations or death in older adults who had gotten COVID-19 shots, according to a new study published in the Journal of the American Medical Association (JAMA) last month. Researchers who tested the COVID treatment Paxlovid (nirmatrelvir-ritonavir) on […]

FDA Official Leaves Agency Through the “Revolving Door” and Returns to Pfizer

FDA Official Leaves Agency Through the “Revolving Door” and Returns to Pfizer

On Feb. 24,2025, Pfizer, Inc. announced that FDA official Patrizia Cavazzoni, MD will rejoin the pharmaceutical company, which makes and sells federally recommended vaccines and drugs, as Pfizer’s Chief Medical Officer and Executive Vice President. Most recently, Dr. Cavazzoni served as Director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food […]

FDA Approves GSK’s 5-in-1 Meningococcal Vaccine

FDA Approves GSK’s 5-in-1 Meningococcal Vaccine

On Feb. 14, 2025, British pharmaceutical and biotechnology company GSK plc announced that the U.S. Food and Drug Administration (FDA) approved its 5-in-1 meningococcal vaccine PENMENVY for licensure and use in individuals aged 10 through 25 years. The vaccine targets five major serogroups of the bacterium Neisseria meningitidis (A, B, C, W, and Y), which […]

Gardasil Lawsuit Worth $8 Billion Set for Jury Trial

Gardasil Lawsuit Worth  Billion Set for Jury Trial

Merck & Co. is about to face a jury trial defending against a claim that Merck advertisements misrepresented that the Gardasil vaccine was safe and effective. The jury will determine whether the drug giant hid the risks and side effects associated with its lucrative HPV (human papilloma virus) vaccine marketed to children and young adults.1 […]

Search in Site

To search in site, type your keyword and hit enter

Search
The Vaccine Reaction
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.